American Journal of Respiratory and Critical Care Medicine, 2025
Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung Disease

Alqalyoobi S., Smith J., Maddali M. et al.

Nutrition & Metabolism, 2025
Unveiling the interplay among skin microbiota, cytokines, and T2DM: an insightful Mendelian randomization study

Zhang Z., Jiang C., Xing Y. et al.

Nature, 2025
Translational genomics of osteoarthritis in 1,962,069 individuals

Hatzikotoulas K., Southam L., Stefansdottir L. et al.

Nature Cancer, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis

Cousin S., Guégan J., Palmieri L. et al.

Brain and Behavior, 2025
Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study

Wang H., Cheng Z., Xu Z. et al.

Cell, 2025
Human proteome distribution atlas for tissue-specific plasma proteome dynamics

Malmström E., Malmström L., Hauri S. et al.

GeroScience, 2025
Associations between plasma proteomic signatures and secondary sleep in older adults

Madhawa K., Svensson T., Nt H. et al.

Scientific Reports, 2025
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis

Miclea A., Zurawski J., Healy B. et al.

Thrombosis Journal, 2025
Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations

Daghlas I., Wang M., Gill D.

Arthritis & Rheumatology, 2025
Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development

Rachid Zaim S., Savage A., Gillespie M. et al.

Cell Reports Medicine, 2025
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients

Hu M., Oliveira A., Fang Z. et al.

Mediators of Inflammation, 2025
Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis

Wu Z., Yang J., Zhu Y. et al.

International Journal of Cancer, 2025
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

Cooley V., Fortner R., Mukama T. et al.

Journal of Proteome Research, 2025
Identification of Salivary Biomarkers in Colorectal Cancer by Integrating Olink Proteomics and Metabolomics

Su H., Gu X., Zhang W. et al.

Urolithiasis, 2025
Effect of the plasma metabolites, biomarkers, and inflammatory proteins on urolithiasis: insights from Mendelian randomization and mediation analysis

Huang H., Wen Z., Li H. et al.

Diabetes Care, 2025
Large-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes

Xie R., Vlaski T., Trares K. et al.

Cell Reports, 2025
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

Molinos-Albert L., Rubio R., Martín-Pérez C. et al.

Cell Reports Medicine, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

Plummer R., Sodergren M., Hodgson R. et al.

Discover Oncology, 2025
Appraising the causal role of cathepsins in genitourinary carcinoma: a two-sample mendelian randomization and prospective study based on 36,225 individuals

Zhu Q., Liu D., Liu H. et al.

Annals of Clinical and Translational Neurology, 2025
CSF Tau Is a Biomarker of Hippocampal Injury in Cryptogenic New‐Onset Refractory Status Epilepticus

Goh Y., Jang Y., Shin S. et al.